Expert Interview
Discussing the use of Actemra for patients with severe Covid-19 infections in light of its recent FDA approval
Ticker(s): RHHBYInstitution: Self-employed
- full time critical care physcian and intensivist with over 20 years of clinical experience
- treats many Covid patients in the most severe form, including all intubated cases.
- experience working with hospitalists outside of ICU as part of a Covid team organized during the pandemic
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
